melanotan 2 pharmacy II MT-II Research Peptide – Peptagon Melanotan 2 (MT-II) | ≥99%
Description
Passez-le sous l'eau tide uniquement

The role of kinetic context in apparent biased agonism at GPCRs

The observation that CTD addition did not affect PLC basal activity argues against this hypothesis, but to further test this idea, we measured binding of purified PLC2 binding to lipid vesicles, in the presence or absence of purified CTD, using a centrifugation-based lipid binding assay

Martin Robert W
